Search Nonprofits

Stand Up To Cancer’s (SU2C) mission is to raise funds to accelerate the pace of groundbreaking translational research that can get new therapies to patients quickly and save lives now. SU2C brings together the best and the brightest researchers and mandates collaboration among the cancer community. By galvanizing the entertainment industry, SU2C has set out to generate awareness, educate the public on cancer prevention and help more people diagnosed with cancer become long-term survivors. Stand Up To Cancer is an initiative of the Entertainment Industry Foundation.

To make all who are touched by invasive lobular breast cancer (also referred to as invasive lobular carcinoma or “ILC”) aware of its unique characteristics and the critical need for more ILC research; to be the go-to source for information on ILC studies, clinical trials and educational tools; to foster partnerships among patients, scientists, clinicians, and breast cancer organizations to increase dialogue about ILC and research advocacy; and to fund vital ILC research. We envision a world in which lobular breast cancer is found early, treated effectively, and eradicated permanently.

Jim Valvano, legendary NC State basketball coach and ESPN announcer, established The V Foundation for Cancer Research in 1993 with ESPN. Its goal is to help find cures for cancer by funding cancer research. It seeks to accomplish this through fundraising, philanthropy, advocacy and education. The Foundation is overseen by a nationally focused volunteer board of directors and is active in all 50 states. The Foundation's Scientific Advisory Board, comprised of an internationally recognized group of research physicians, reviews grant proposals, selects research projects to support and continues to identify new and alternative ways to become a leader in the field of cancer research.

Our mission is to find a cure and improve the quality of life for those affected by cholangiocarcinoma (bile duct cancer). Founded in 2006, the Cholangiocarcinoma Foundation provides education and collaborative opportunities for patients, caregivers, doctors, researchers, industry, and other partners invested in bile duct cancer. We provide services throughout the United States and internationally. In addition to funding research, services include an annual three-day conference, complimentary publications in four languages (English, Spanish, Japanese and Chinese), a free online book "100 Questions and Answers About Biliary Cancer", an informational website, a patient registry, phone/email support and a robust discussion board.

Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. After decades of investigation, scientists have unlocked the power of our body's own immune system to fight cancer. This class of treatments—called cancer immunotherapy—enhances a patient's immune system to identify and eliminate cancer cells, anywhere in the body. Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization that is dedicated to saving more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. We fund the most innovative clinical and laboratory research around the world, support the next generation of the field's leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. CRI's programs provide strategic support along the entire pathway of discovery, drug development, and patient support.

From the website: "American Lebanese Syrian Associated Charities (ALSAC) was founded by Danny Thomas in 1957 to be the fundraising and awareness organization for St. Jude Children’s Research Hospital, and its sole mission is to raise the funds and awareness necessary to operate and maintain the hospital. In the years ahead, an estimated 89% of the funds necessary to sustain and grow St. Jude must be raised by ALSAC from generous donors."